Frankfurt - Delayed Quote • EUR
Elicio Therapeutics, Inc. (9HA.F)
As of 9:59 AM GMT+2. Market Open.
Key Executives
Key Executives Information Not Available
Elicio Therapeutics, Inc.
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Elicio Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
May 08, 2024 - May 13, 2024
Elicio Therapeutics, Inc. Earnings Call